The mu opioid receptor A118G gene polymorphism moderates effects of trait anger-out on acute pain sensitivity
- 15 October 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pain
- Vol. 139 (2), 406-415
- https://doi.org/10.1016/j.pain.2008.05.014
Abstract
Both trait anger-in (managing anger through suppression) and anger-out (managing anger through direct expression) are related to pain responsiveness, but only anger-out effects involve opioid mechanisms. Preliminary work suggested that the effects of anger-out on postoperative analgesic requirements were moderated by the A118G single nucleotide polymorphism of the mu opioid receptor gene. This study further explored these potential genotype × phenotype interactions as they impact acute pain sensitivity. Genetic samples and measures of anger-in and anger-out were obtained in 87 subjects (from three studies) who participated in controlled laboratory acute pain tasks (ischemic, finger pressure, thermal). McGill Pain Questionnaire (MPQ) Sensory and Affective ratings for each pain task were standardized within studies, aggregated across pain tasks, and combined for analyses. Significant anger-out × A118G interactions were observed (p’s < .05). Simple effects tests for both pain measures revealed that whereas anger-out was nonsignificantly hyperalgesic in subjects homozygous for the wild-type allele, anger-out was significantly hypoalgesic in those with the variant G allele (p’s < .05). For the MPQ-Affective measure, this interaction arose both from low pain sensitivity in high anger-out subjects with the G allele and heightened pain sensitivity in low anger-out subjects with the G allele relative to responses in homozygous wild-type subjects. No genetic moderation was observed for anger-in, although significant main effects on MPQ-Affective ratings were noted (p < .005). Anger-in main effects were due to overlap with negative affect, but anger-out × A118G interactions were not, suggesting unique effects of expressive anger regulation. Results support opioid-related genotype × phenotype interactions involving trait anger-out.Keywords
This publication has 38 references indexed in Scilit:
- Trait anger expressiveness and pain-induced beta-endorphin release: Support for the opioid dysfunction hypothesisPain, 2007
- Anger Management Style and Endogenous Opioid Function: Is Gender a Moderator?Journal of Behavioral Medicine, 2007
- Anger Expression and Pain: An Overview of Findings and Possible MechanismsJournal of Behavioral Medicine, 2006
- Anger Regulation Style, Postoperative Pain, and Relationship to the A118G Mu Opioid Receptor Gene Polymorphism: A Preliminary StudyJournal of Behavioral Medicine, 2006
- The association between anger expression and chronic pain intensity: evidence for partial mediation by endogenous opioid dysfunctionPain, 2003
- Anger and pain sensitivity in chronic low back pain patients and pain-free controls: the role of endogenous opioidsPain, 2002
- Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addictionProceedings of the National Academy of Sciences, 1998
- The moderator–mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations.Journal of Personality and Social Psychology, 1986
- Inability to express intense affect: A common link between depression and pain?Journal of Consulting and Clinical Psychology, 1986
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961